Trial · NCT02714426
A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults
NCT02714426, Not applicable, Completed, University of Florida; results first posted 2019-02-21
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults. Trials, record NCT02714426. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02714426
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults
- NCT number
- NCT02714426
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 42 participants, actual
- Lead sponsor
- University of Florida
- Conditions
- Cognitive Aging
- Interventions
- Mindfulness-inspired treatment, Brain health
- First posted
- 2016-03-21
- Last updated
- 2019-03-07
- Results first posted
- 2019-02-21
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | The Attention Network Task is a computerized test that measures three different components of attention (alerting, orienting, and conflict monitoring). Score is the computed as the difference between reaction time on correct trials in cued and uncued conditions. Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse) |
| Secondary | Performance in Useful Field of View Over 14 Weekly Measurements | Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | The useful field of view task is a computer-administered selective visual attention test that determines the minimum presentation time needed (between 16-500 msec) to correctly make two visual judgments: (a) is a centrally presented line drawing of a car or truck? and (b) where on the screen is a peripheral car located? Score is the fastest presentation time at which participants achieve at least 75% accuracy. Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse) |
| Secondary | Performance in Stroop Interference Over 14 Weekly Measurements | Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | This task set is computerized presents participants with a word (red or green or blue) that may be presented in (a) congruent (same) color as the word itself (e.g., red word is printed in red), or (b) incongruent (word red printed in green or blue). Participants are cued to either select the word or the color, this varies from trial to trial. Score is the reaction time difference between correct responses to congruent and incongruent stimuli. Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse) |
| Other | Self-ratings of Perceived Mind Wandering Over 8 Weekly Measurements | Self-ratings of weeks 4, 5, 6, 7, 8, 9, 10, 11 | Participants in both arms are asked, at the end of each of their eight intervention sessions, to focus on breathing. They are interrupted five times during this breathing exercise and asked what proportion of their attention (0-100) was wandering off the breathing task. Score is the average proportion of self-rated mind-wandering over five probes. Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse) |
| Other | Self-ratings in Anxiety (GAD-7) Questionnaire Over 14 Weekly Measurements | Self-ratings in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | Participants will answer computer 7 administered questions about anxiety in the past week. Score is a Likert-type scale response from the following scale: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Scores have been normalized via Blom transformation and computed to T-score metric (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = worse) |
| Other | Self-ratings on Cognitive and Affective Mindfulness Scale (CAMSr) Over 14 Weekly Measurements | Self-ratings weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | Cognitive and Affective Mindfulness Scale (CAMSr) will be computer administered. It is a psychological measurement to explore mindfulness. Each week ten items are rated on a 4-point Likert-type scale (1=rarely/never, 2=sometimes, 3=often, 4=almost always). Higher scores indicate greater cognitive and emotional focus. Scores are the average of the ten items, normalized and converted to T-score (mean=50, standard deviation = 10, minimum = 0, maximum = 100, higher = better) metric. |
Source ClinicalTrials.gov
Outcomes6
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | Intent to treat analysis via mixed effects modeling; all available data were used at each occasion. Participants were not able to attend all sessions. | units on a scale | MEAN |
| SECONDARY | Performance in Useful Field of View Over 14 Weekly Measurements | Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | Intent to treat analysis via mixed effects modeling; all available data were used at each occasion. Participants were not able to attend all sessions. | units on a scale | MEAN |
| SECONDARY | Performance in Stroop Interference Over 14 Weekly Measurements | Performance in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | Intent to treat analysis via mixed effects modeling; all available data were used at each occasion. Participants were not able to attend all sessions. | units on a scale | MEAN |
| OTHER_PRE_SPECIFIED | Self-ratings of Perceived Mind Wandering Over 8 Weekly Measurements | Self-ratings of weeks 4, 5, 6, 7, 8, 9, 10, 11 | Intent to treat analysis via mixed effects modeling; all available data were used at each occasion. Participants were not able to attend all sessions. | units on a scale | MEAN |
| OTHER_PRE_SPECIFIED | Self-ratings in Anxiety (GAD-7) Questionnaire Over 14 Weekly Measurements | Self-ratings in weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | Intent to treat analysis via mixed effects modeling; all available data were used at each occasion. Participants were not able to attend all sessions. | units on a scale | MEAN |
| OTHER_PRE_SPECIFIED | Self-ratings on Cognitive and Affective Mindfulness Scale (CAMSr) Over 14 Weekly Measurements | Self-ratings weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 | Intent to treat analysis via mixed effects modeling; all available data were used at each occasion. Participants were not able to attend all sessions. | units on a scale | MEAN |
Source ClinicalTrials.gov
Results by group156
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Brain Health | Week1 | 51.6 | Standard Deviation 14.4 | units on a scale |
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Mindfulness-inspired Treatment/Testing | Week1 | 60.4 | Standard Deviation 8.0 | units on a scale |
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Brain Health | Week2 | 51.2 | Standard Deviation 11.7 | units on a scale |
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Mindfulness-inspired Treatment/Testing | Week2 | 57.3 | Standard Deviation 10.9 | units on a scale |
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Brain Health | Week3 | 50.4 | Standard Deviation 7.6 | units on a scale |
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Mindfulness-inspired Treatment/Testing | Week3 | 57.1 | Standard Deviation 7.7 | units on a scale |
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Brain Health | Week4 | 48.8 | Standard Deviation 8.3 | units on a scale |
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Mindfulness-inspired Treatment/Testing | Week4 | 57.9 | Standard Deviation 9.9 | units on a scale |
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Brain Health | Week5 | 48.2 | Standard Deviation 9.8 | units on a scale |
| Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements | Mindfulness-inspired Treatment/Testing | Week5 | 53.8 | Standard Deviation 10.4 | units on a scale |
1 to 10 of 156Source ClinicalTrials.gov
See all 156 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Brain Health | 21 | |
| Overall Study | STARTED | Mindfulness-inspired Treatment/Testing | 21 | |
| Overall Study | COMPLETED | Brain Health | 19 | |
| Overall Study | COMPLETED | Mindfulness-inspired Treatment/Testing | 19 | |
| Overall Study | NOT COMPLETED | Brain Health | 2 | |
| Overall Study | NOT COMPLETED | Mindfulness-inspired Treatment/Testing | 2 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Brain Health | 0 | 21 |
| Total, all-cause mortality | Mindfulness-inspired Treatment/Testing | 0 | 21 |
| Total, other adverse events | Brain Health | 0 | 21 |
| Total, other adverse events | Mindfulness-inspired Treatment/Testing | 0 | 21 |
| Total, serious adverse events | Brain Health | 0 | 21 |
| Total, serious adverse events | Mindfulness-inspired Treatment/Testing | 0 | 21 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| F31AG051356 | A 14 week study of mindfulness effects on attentional control in older adults | MAYE, JACQUELINE E | UNIVERSITY OF FLORIDA | NATIONAL INSTITUTE ON AGING | 2016 to 2017 |
Source NIH RePORTER
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Brain Health vs Mindfulness-inspired Treatment/Testing: deaths from any cause | Trial comparisons |
| Brain Health vs Mindfulness-inspired Treatment/Testing: serious adverse events | Trial comparisons |
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Attention Network Test | Primary outcome | ConductCognition |
| Field of View Speed Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02714426
GET https://conductscience.org/api/trials/v1/NCT02714426/results?page=2